Making our innovation accessible
Despite remarkable breakthroughs in treating disease, ensuring that patients have access to these breakthroughs remains a significant challenge. Our main contribution to this challenge is to deliver innovation by developing medicines that prolong and improve people’s lives. However, we also work with many different partners to reduce barriers that prevent people from being diagnosed or being treated with our products.
As healthcare systems around the world are very different and complex, we do not have a single approach, but provide tailored solutions to address the needs of each individual country: including innovative pricing models, patient access programs, health infrastructure and health education programs. Our aim is for every person who needs our products to be able to access them and benefit from them.
To read about the Blue Tree program click here